1. Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer

   • Alberto Ocaña
   • Javier Pérez-Peña
   • Atanasio Pandiella

   Preclinical Study 20 February 2016 Pages: 1 - 8

   

2. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts

   • Mohammed A. Aleskandarany
   • Devika Agarwal
   • Emad A. Rakha

   Preclinical study 23 February 2016 Pages: 9 - 20

   

3. Whole exome sequencing of rare aggressive breast cancer histologies

   • Maria Vittoria Dieci
   • Veronika Smutná
   • Celine Lefebvre

   Preclinical Study 23 February 2016 Pages: 21 - 32

   

4. Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

   • Sanja B. Turturro
   • Matthew S. Najor
   • Abde M. Abukhdeir

   Preclinical study Open access 25 February 2016 Pages: 33 - 43

   

5. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas

   • Mayu Takagi
   • Yasuhiro Miki
   • Hironobu Sasano

   Preclinical study 04 March 2016 Pages: 45 - 55

   

6. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells

   • Indira Pandiri
   • Yingqing Chen
   • Jeong Woo Park

   Preclinical study Open access 08 March 2016 Pages: 57 - 64

   

7. MSCs and inflammation: new insights into the potential association between ALCL and breast implants

   • M. Orciani
   • G. Sorgentoni
   • G. Di Benedetto

   Preclinical Study 08 March 2016 Pages: 65 - 72

   

8. A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer

   • Dimitrios Dionyssiou
   • Efterpi Demiri
   • Georgios Arsos

   Clinical trial 19 February 2016 Pages: 73 - 79

9. Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study

   • Miguel Martin
   • Jan C. Brase
   • Alvaro Rodriguez-Lescure

   Clinical trial Open access 24 February 2016 Pages: 81 - 89

   

10. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score

    • Andreas D. Hartkopf
    • Markus Wallwiener
    • Sara Y. Brucker

    Clinical trial 25 February 2016 Pages: 91 - 95

    

11. Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial

    • A. Welt
    • N. Marschner
    • S. Hegewisch-Becker

    Clinical trial Open access 29 February 2016 Pages: 97 - 107

    

12. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium

    • Emily F. Conant
    • Elisabeth F. Beaber
    • William E. Barlow

    Clinical trial 01 March 2016 Pages: 109 - 116

    

13. A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer

    • T. Zhu
    • C. L. Liu
    • K. Wang

    Clinical trial 02 March 2016 Pages: 117 - 124

    

14. Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study

    • Minish M. Jain
    • Smita U. Gupte
    • Shravanti Bhowmik

    Clinical trial Open access 03 March 2016 Pages: 125 - 134

    

15. Lin28A and androgen receptor expression in ER−/Her2+ breast cancer

    • Honghong Shen
    • Yong Yang
    • Yun Niu

    Clinical trial 05 March 2016 Pages: 135 - 147

    

16. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis

    • Jieqiong Liu
    • Huishan Guo
    • Qiang Liu

    Epidemiology 22 February 2016 Pages: 149 - 162

    

17. Childhood body mass index and adult mammographic density measures that predict breast cancer risk

    • John L. Hopper
    • Tuong L. Nguyen
    • Carmel Apicella

    Epidemiology 23 February 2016 Pages: 163 - 170

    

18. iPrevent^®: a tailored, web-based, decision support tool for breast cancer risk assessment and management

    • Ian M. Collins
    • Adrian Bickerstaffe
    • Kelly-Anne Phillips

    Epidemiology Open access 24 February 2016 Pages: 171 - 182

    

19. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis

    • Lauren E. McCullough
    • Jia Chen
    • Marilie D. Gammon

    Epidemiology 05 March 2016 Pages: 183 - 194

20. Study of breast cancer incidence in patients of lymphangioleiomyomatosis

    • Olivier Nuñez
    • Antonio Román
    • Miguel Angel Pujana

    Epidemiology Open access 07 March 2016 Pages: 195 - 201

    

21. Comments on ‘Brief screening of patients with distressing fear of recurrence in breast cancer survivors’ by Akechi et al., Breast Cancer Res Treat, 2015, 153(2): pp. 475–476

    • B. Thewes
    • M. van de Wal
    • J. Prins

    Letter to the Editor 25 February 2016 Pages: 203 - 204

22. Author reply: Brief screening of breast cancer survivors with distressing fear of recurrence

    • Tatsuo Akechi
    • Kanae Momino
    • Hiroji Iwata

    Rebuttal Letter 25 February 2016 Pages: 205 - 206

23. Erratum to: JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3

    • Liliang Li
    • Pan Gao
    • Jieqing Jiang

    Erratum 23 February 2016 Pages: 207 - 208

    

24. Erratum to: Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo

    • Elke Ziegler
    • Marie-Therese Hansen
    • Carsten Gründker

    Erratum 01 March 2016 Pages: 209 - 210